A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis

Conditions

• Atopic Dermatitis

Eligibility Criteria

Sex

ALL

Age

3 Months - 23 Months

Healthy Volunteers

Not accepted

Interventions

• Tapinarof cream, 1% — DRUG
  Tapinarof cream, 1%: Applied topically once daily to lesions on participant's skin during the Double-Blind period. During the Open-Label Period, it will be applied once daily to lesions, as needed.
• Vehicle Cream — DRUG
  Applied topically once daily to lesions on participant's skin during the Double-Blind period.

Study Details

The purpose of this global Phase 3 clinical study is to investigate the safety and efficacy of tapinarof cream, 1% in participants ages 3 months to 23 months (inclusive) with atopic dermatitis.

Key Dates

First listed

Dec 4, 2025

Start date

Dec 29, 2025

Status verified

Aug 2026

Primary completion

Aug 31, 2027

Completion

Aug 31, 2027

Study Design

Enrollment

187 participants (actual)

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Arms

• Experimental: Tapinarof cream
  Tapinarof cream, 1%, applied topically once daily
• Placebo Comparator: Vehicle cream
  Vehicle cream is applied topically once daily for up to 8-weeks.

Primary Outcome Measure

Percentage of participants who have a validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD) score of clear or almost clear (0 or 1) and a minimum 2-grade Improvement from Baseline to Week 8 [ Time Frame: Baseline to last planned visit in the Double-Blind Period, up to 8 weeks. ]

Locations (36)

Find similar trials in Birmingham, AL

Related Studies

• Studies of Skin Microbes in Healthy People and in People With Skin Conditions
  Recruiting · National Human Genome Research Institute (NHGRI) · Bethesda, Maryland
• Natural History and Genetics of Food Allergy and Related Conditions
  Recruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Bethesda, Maryland
• Skin Microbial Ecology in Atopic Dermatitis
  Recruiting · University of Rochester · Rochester, New York
• Metabolic Profiling of Immune Responses in Immune-mediated Diseases
  Recruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Bethesda, Maryland